Literature DB >> 3579974

Metabolism of adriamycin in hepatocytes isolated from the rat and the rabbit.

D A Gewirtz, S Yanovich.   

Abstract

Metabolism of adriamycin, an anthracycline antibiotic, was characterized in both rat and rabbit hepatocytes under aerobic conditions. Adriamycin was the predominant fluorescent species within the cell in hepatocytes from both the rat and the rabbit. In the rat hepatocyte, the primary intracellular metabolite was deoxyadriamycin aglycone, while significant levels of deoxyadriamycinol aglycone were also synthesized; little adriamycinol was observed in the cells or the incubation medium. In contrast, in the rabbit hepatocyte, significant levels of adriamycinol as well as deoxyadriamycinol aglycone were formed; deoxyadriamycinol aglycone was the primary intracellular metabolite while low levels of deoxyadriamycin aglycone were observed. The relative formation of deoxyadriamycinol aglycone and deoxyadriamycin aglycone suggests that adriamycinol may be metabolized more effectively to the deoxyaglycone derivative than the parent drug. Conjugates of adriamycin were not observed in hepatocytes from either the rat or the rabbit or in the incubation medium.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3579974     DOI: 10.1016/0006-2952(87)90240-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  4 in total

1.  Combination of micellar electrokinetic and high-performance liquid chromatographies to assess age-related changes in the in vitro metabolism of Fischer 344 rat liver.

Authors:  Yaohua Wang; Joseph B Katzenmeyer; Edgar A Arriaga
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-07-11       Impact factor: 6.053

2.  A novel method to detect intracellular metabolite alterations in MCF-7 cells by doxorubicin induced cell death.

Authors:  Ajay Kumar; Sheetal Patel; Devyani Bhatkar; Sachin C Sarode; Nilesh Kumar Sharma
Journal:  Metabolomics       Date:  2021-01-03       Impact factor: 4.290

3.  Quantitation of cell-associated doxorubicin by high-performance liquid chromatography after enzymatic desequestration.

Authors:  A Andersen; D J Warren; L Slørdal
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

4.  Comparative metabolism and pharmacokinetics of doxorubicin and 4'-epidoxorubicin in plasma, heart and tumor of tumor-bearing mice.

Authors:  W J van der Vijgh; P A Maessen; H M Pinedo
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.